NICE technology appraisal guidance
Issued: May 2003
TA61
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer
This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta61
Important information about this guidance
In April 2006, following consultation, the Institute decided to make this guidance 'static.' This means that the guidance remains in force and has no scheduled review date. See www.nice.org.uk/guidance/TA61 for details.